Oskar Eriksson – Translational studies of the complement system
We are studying the body’s complement system, which is part of the innate immune system. We are interested in the mechanism behind how the complement system is activated in humans, and its role in diseases characterized by systemic inflammation. An important aim of our research is to develop and refine complement diagnostics.
The complement system constitutes one of the branches of the innate immune system and functions as an intravascular surveillance system that serves to purge the vascular system of pathogens and cellular debris.
It accomplishes these tasks by tagging foreign surfaces with powerful opsonins, by generating potent pro-inflammatory mediators at sites of activation, and by directly lysing target cells through cell-surface assembly of the membrane attack complex (MAC). Recently, the discovery of non-canonical intracellular functions of complement factors has opened up a new research direction in the complement field.
Activation via the lectin pathway
We are focusing our efforts on the lectin pathway, one of the three main complement activation pathways and the most recent one to be discovered. The lectin pathway is activated by a series of circulating pattern recognition molecules that trigger complement activation through complex-bound Masp proteases upon target recognition (see figure below).
Most studies of the lectin pathway have focused on mannose-binding lectin (MBL) as this was the first component to be discovered, and constitutes the major lectin pathway initiator in rodents. However, the lectin pathway has undergone considerable evolution after branching of the rodent lineage, and is mainly initiated in humans by ficolin-3, a primate-specific pattern recognition molecule that does not exist in rodents.
Ficolin-3 circulates in plasma in high concentration, but has an unknown function and a poorly defined binding specificity. Hence, the physiological role of ficolin-3 constitutes an important knowledge gap in the complement field that we are aiming to address.

Overview of complement activation via the lectin pathway. Pattern recognition molecules (MBL, collectins or ficolins) bind to pathogens or damage-associated molecular patterns exposed on cell surfaces to trigger complement activation via associated Masp proteases (yellow). Activation of complement C3 to C3b leads to opsonization, and eventually membrane attack complex (MAC) formation.
Publications
Part of Journal of Autoimmunity, 2024
- DOI for A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile
- Download full text (pdf) of A survey of ficolin-3 activity in Systemic Lupus Erythematosus reveals a link to hematological disease manifestations and autoantibody profile
Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination
Part of Scientific Reports, 2024
- DOI for Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination
- Download full text (pdf) of Autoantibodies to protein S may explain rare cases of coagulopathy following COVID-19 vaccination
Part of Journal of Innate Immunity, p. 412-427, 2023
- DOI for Combined Heterozygous Genetic Variations in Complement C2 and C8B: An Explanation for Multidimensional Immune Imbalance?
- Download full text (pdf) of Combined Heterozygous Genetic Variations in Complement C2 and C8B: An Explanation for Multidimensional Immune Imbalance?
Part of Blood Advances, p. 6367-6380, 2023
- DOI for Complement and platelets: prothrombotic cell activation requires membrane attack complex-induced release of danger signals
- Download full text (pdf) of Complement and platelets: prothrombotic cell activation requires membrane attack complex-induced release of danger signals
Part of Frontiers in Immunology, 2023
- DOI for How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system
- Download full text (pdf) of How COVID-19 and other pathological conditions and medical treatments activate our intravascular innate immune system
Part of Scandinavian Journal of Rheumatology, p. 214-219, 2022
- DOI for Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis-A Swedish biobank study
- Download full text (pdf) of Complement activation prior to symptom onset in myeloperoxidase ANCA-associated vasculitis but not proteinase 3 ANCA associated vasculitis-A Swedish biobank study
Part of Nature Immunology, p. 861-864, 2022
Part of Frontiers in Immunology, 2022
- DOI for How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment
- Download full text (pdf) of How the Innate Immune System of the Blood Contributes to Systemic Pathology in COVID-19-Induced ARDS and Provides Potential Targets for Treatment
Part of Journal of clinical medicine, 2022
- DOI for Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients.
- Download full text (pdf) of Impaired Antibody Response Is Associated with Histone-Release, Organ Dysfunction and Mortality in Critically Ill COVID-19 Patients.
Part of Frontiers in Immunology, 2021
- DOI for The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
- Download full text (pdf) of The Outcome of Critically Ill COVID-19 Patients Is Linked to Thromboinflammation Dominated by the Kallikrein/Kinin System
Blood type A associates with critical COVID-19 and death in a Swedish cohort
Part of Critical Care, 2020
- DOI for Blood type A associates with critical COVID-19 and death in a Swedish cohort
- Download full text (pdf) of Blood type A associates with critical COVID-19 and death in a Swedish cohort
Part of Thrombosis and haemostasis, p. 1720-1724, 2020
Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics
Part of Frontiers in Immunology, 2019
- DOI for Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics
- Download full text (pdf) of Current and Future Approaches for Monitoring Responses to Anti-complement Therapeutics
Part of Frontiers in Immunology, 2019
- DOI for The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System
- Download full text (pdf) of The Human Platelet as an Innate Immune Cell: Interactions Between Activated Platelets and the Complement System
First-in-class PET tracer for the glucagon receptor
Part of Diabetologia, 2017
Part of Thrombosis and Haemostasis, p. 1050-1059, 2016
Part of BMC Cancer, 2016
- DOI for Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer
- Download full text (pdf) of Cross-talk between the Tissue Factor/coagulation factor VIIa complex and the tyrosine kinase receptor EphA2 in cancer
Part of Journal of Thrombosis and Haemostasis, p. 111-111, 2015
Part of Scandinavian Journal of Clinical and Laboratory Investigation, p. 428-433, 2015
Tissue Factor Noncoagulant Signaling: Mechanisms and Implications for Cell Migration and Apoptosis
Part of Seminars in Thrombosis and Hemostasis, p. 691-699, 2015
Part of Journal of Biological Chemistry, 2014
Part of Thrombosis and Haemostasis, p. 748-760, 2014
The insulin-like growth factor 1 receptor mediates tissue factor/FVIIa-induced cell survival
Part of Journal of Thrombosis and Haemostasis, p. 171-172, 2013